These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4278575)

  • 1. [Case of allergic reaction to vincaton].
    Zelikov AKh; Danilov LN
    Klin Med (Mosk); 1974; 52(8):136-7. PubMed ID: 4278575
    [No Abstract]   [Full Text] [Related]  

  • 2. Open-labeled phase III clinical trials with vinpocetine in Japan.
    Ebi O
    Ther Hung; 1985; 33(1):41-9. PubMed ID: 3915913
    [No Abstract]   [Full Text] [Related]  

  • 3. [Strong delayed-action pervincamine in general medicine].
    Warembourg H; Ketelers JY
    Lille Med; 1975 Apr; 20(4):424-7. PubMed ID: 1152596
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK; Blechacz W
    Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of the effect of Devincan and Stugeron in patients suffering from cerebrovascular diseases treated at medical departments.
    Udvarhelyi A
    Ther Hung; 1978; 26(1):29-32. PubMed ID: 663872
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E; Di Lorenzo L; De Pergola G
    G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pervincamine in the treatment of the cerebrovascular syndrome in the gerontopsychiatric patients].
    Fidetzis K; Brosteano R; Keller P
    Med Welt; 1976 Jul; 27(29):1412-4. PubMed ID: 785150
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
    Periti P; Periti G; Colombo Pirola L
    Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of two years' Cavinton treatment on the ECG.
    Farsang C; Kertész G; Bánki MC; Juvancz P
    Ther Hung; 1987; 35(3):125-8. PubMed ID: 3438872
    [No Abstract]   [Full Text] [Related]  

  • 11. [Polymorphic effects of cavinton: experimental and clinical evidence].
    Kasatkin DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9 Pt 2):8-12. PubMed ID: 21465683
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and experimental evaluation of the use of eburnamonine in acute anc chronic cerebro-vascular insufficiency].
    Rampello L; Barbagallo G; Costanzo E; Sciacca A; Russo S
    Clin Ter; 1981 Feb; 96(4):371-81. PubMed ID: 7214860
    [No Abstract]   [Full Text] [Related]  

  • 13. Cavinton in the treatment of acute stroke.
    Kovács L
    Ther Hung; 1985; 33(1):50-7. PubMed ID: 3841999
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of 2 drugs used in the treatment of cerebral vascular insufficiency: I-Eburnamonine and Vincamine].
    Linquette M
    Lille Med; 1978 May; 23(5 Suppl 1):379-81. PubMed ID: 682847
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of psychophysiologic characteristics of patients in the efficacy of treatment with cavinton].
    Lil'in ET; Mar'in MI; Trubnikov VI; Vavilova TA
    Sov Med; 1983; (10):111-3. PubMed ID: 6658534
    [No Abstract]   [Full Text] [Related]  

  • 16. [About cavinton therapy of the patients with brain vascular diseases].
    Nikitina VV; Pravdina AN; Zapatrina OV
    Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of treatment with Vincimax in 60 cases of cerebral circulatory insufficiency].
    Desruelles J; Camart JF
    LARC Med; 1981 Dec; 1(3):86-90. PubMed ID: 7349693
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
    Kauchtschischvili G; Nappi G; Bono G
    Minerva Med; 1974 May; 65(40):2296-315. PubMed ID: 4608671
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
    Franzini C; Ferrante P
    Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of cavinton in neuropaediatrics].
    Studenikin VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):63-4. PubMed ID: 15847328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.